Physician

Adam Ahmed Zuber, M.D.

According to 2025 Medicare claims, Adam Zuber, M.D. (NPI: 1285670240) practices neurology in the Riverside-San Bernardino-Ontario, CA market, with the plurality of this provider's patient population coming from Riverside, CA. This provider's primary affiliated billing organization is RIVERSIDE MEDICAL CLINIC, INC (NPI: 1730180415; TIN: 330587303) and primary practice location at 92883-6100. Zuber is affiliated with the CALIFORNIA CLINICAL PARTNERS ACO, LLC (ACO ID: A4709), participating under the MSSP model.

Zuber's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 75 traditional Medicare patients, billed 213 HCPCS/CPT codes, and received $30,374 in Medicare payments. The top billing code was 95819 (Measurement of brain wave activity (eeg), awake and asleep). Part D data shows 1,249 prescription claims across 231 beneficiaries totaling $112,481 in drug costs, led by Briviact (Brivaracetam). 2017 DME data shows 35 claims. Open Payments data shows 8 records totaling $148. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing started with an early spike, then settled into a lower baseline, moving from $146,055 to $30,374. Similarly, Part D prescription costs have declined steadily, from $338,083 to $112,481. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	320	1,128	$146,055
2016	257	1,289	$164,914
2017	283	1,080	$131,246
2018	269	1,174	$161,224
2019	180	500	$67,724
2020	81	284	$35,941
2021	83	373	$61,917
2022	90	323	$53,278
2023	79	342	$54,498
2024	75	213	$30,374

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	270	1,225	$338,083
2016	329	1,680	$464,426
2017	375	1,915	$455,647
2018	484	2,881	$471,183
2019	328	1,495	$341,316
2020	109	245	$21,871
2021	231	1,110	$105,061
2022	275	1,569	$184,746
2023	238	1,462	$186,532
2024	231	1,249	$112,481

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	28	$2,281
2017	N/R	35	$595
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
95819	Measurement of brain wave activity (eeg), awake and asleep	13	13	$384
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	37	37	$169
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	41	66	$120
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	30	36	$105
95886	Needle measurement of electrical activity in arm or leg muscles, complete study	11	30	$80

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Briviact	Brivaracetam	30	1,140	$59,232
Carbidopa-Levodopa Er	Carbidopa/Levodopa	100	6,190	$8,307
Emgality Pen	Galcanezumab-Gnlm	12	360	$8,059
Memantine Hcl	Memantine Hcl	294	17,386	$7,176
Memantine Hcl Er	Memantine Hcl	11	510	$3,087

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	8	$148	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Adam Ahmed Zuber, M.D.?

Tedicare shows public-source Medicare data for Adam Ahmed Zuber, M.D. (NPI 1285670240), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adam Ahmed Zuber, M.D. have ACO affiliation data?

Adam Ahmed Zuber, M.D. is shown with ACO affiliation data for CALIFORNIA CLINICAL PARTNERS ACO, LLC (MSSP, ACO ID A4709).

What billing organization is linked to Adam Ahmed Zuber, M.D.?

Adam Ahmed Zuber, M.D. is linked to RIVERSIDE MEDICAL CLINIC, INC (billing NPI 1730180415) in the available physician profile data.

Does Adam Ahmed Zuber, M.D. have Open Payments data?

Adam Ahmed Zuber, M.D. has 8 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.